Advertisement
Research Article| Volume 7, ISSUE 4, P829-850, October 1991

Management of Severe Preeclampsia and Eclampsia

  • Gary A. Dildy III
    Correspondence
    Address reprint requests to Gary A. Dildy III, MD, Department of Perinatology, Utah Valley Regional Medical Center, 1034 North 500 West, Provo, UT 84604
    Affiliations
    Assistant Professor, Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, Utah
    Search for articles by this author
  • David B. Cotton
    Affiliations
    Professor and Chairman, Department of Obstetrics and Gynecology, Wayne State University/Hutzel Hospital, Detroit Medical Center, Detroit, Michigan
    Search for articles by this author
DOI:https://doi.org/10.1016/S0749-0704(18)30283-5
Management of Severe Preeclampsia and Eclampsia
Previous ArticleClinical Management of Thromboembolic Disorders in Pregnancy
Next ArticleIntrapartum Obstetric Emergencies
      This paper is only available as a PDF. To read, Please Download here.
      Preeclampsia/eclampsia is a disorder unique to the obstetric patient and is often associated with poor maternal and perinatal outcome. The multisystemic nature of this disorder may lead to severe dysfunction of almost any organ system. In addition to these often critically ill patients, the health care provider must also manage the pregnant patient in whom preeclampsia is present but not recognized as the precipitating factor leading to systemic dysfunction. A thorough understanding of this disease is essential to the critical care specialist as well as the obstetrician/ gynecologist and perinatologist.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abdella T.N.
        • Sibai B.M.
        • Hays Jr., J.M.
        • et al.
        Relationshiop of hypertensive disease to abruptio placentae.
        Obstet Gynecol. 1984; 63: 365-370
        • Andersen H.F.
        • Lynch J.P.
        • Johnson T.RB.
        Adult respiratory distress syndrome in obstetrics and gynecology.
        Obstet Gynecol. 1980; 55: 291-295
        • Arias F.
        • Mancilla-Jimenez R.
        Hepatic fibrinogen deposits in pre-eclampsia.
        N Engl J Med. 1976; 295: 578-582
        • Assali N.S.
        • Kaplan S.
        • Oighenstein S.
        • et al.
        Hemodynamic effects of 1-hydrazinophthalazine (Apresoline) in human pregnancy: Results of intravenous administration.
        J Clin Invest. 1953; 32: 922-930
        • Bell B.A.
        A history of the study of cerebral edema.
        Neurosurgery. 1983; 13: 724-728
        • Benedetti T.J.
        • Carlson R.W.
        Studies of colloid osmotic pressure in pregnancy-induced hypertension.
        Am J Obstet Gynecol. 1979; 135: 308-311
        • Benedetti T.J.
        • Quilligan E.J.
        Cerebral edema in severe pregnancy-induced hypertension.
        Am J Obstet Gynecol. 1980; 137: 860-862
        • Benedetti T.J.
        • Kates R.
        • Williams V.
        Hemodynamic observations in severe preeclampsia complicated by pulmonary edema.
        Am J Obstet Gynecol. 1985; 152: 330-334
        • Borges L.F.
        • Gucer G.
        Effect of magnesium on epileptic foci.
        Epilepsia. 1978; 19: 81-91
        • Burrows R.F.
        • Hunter D.JS.
        • Andrew M.
        • et al.
        A prospective study investigating the mechanism of thrombocytopenia in preeclampsia.
        Obstet Gynecol. 1987; 70: 334-338
        • Chesley L.C.
        Plasma and red cell volumes during pregnancy.
        Am J Obstet Gynecol. 1972; 112: 440-450
        • Chesley L.C.
        Parenteral magnesium sulfate and the distribution, plasma levels, and excretion of magnesium.
        Am J Obstet Gynecol. 1979; 133: 1-7
        • Chesley L.C.
        History and epidemiology of preeclampsia-eclampsia.
        Clin Obstet Gynecol. 1984; 27: 801-820
        • Chesley L.C.
        Diagnosis of preeclampsia.
        Obstet Gynecol. 1985; 65: 423-425
        • Chesley L.C.
        • Duffus G.M.
        Preeclampsia, posture, and renal function.
        Obstet Gynecol. 1971; 38: 1-5
        • Clark S.L.
        • Cotton D.B.
        Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia.
        Am J Obstet Gynecol. 1988; 158: 453-458
        • Clark S.L.
        • Cotton D.B.
        • Lee W.
        • et al.
        Central hemodynamic assessment of normal term pregnancy.
        Am J Obstet Gynecol. 1989; 161: 1439-1442
        • Clark S.L.
        • Divon M.Y.
        • Phelan J.P.
        Preeclampsia/eclampsia: Hemodynamic and neurologic correlations.
        Obstet Gynecol. 1985; 66: 337-340
        • Clark S.L.
        • Greenspoon J.S.
        • Aldahl D.
        • et al.
        Severe preeclampsia with persistent oliguria: Management of hemodynamic subsets.
        Am J Obstet Gynecol. 1986; 154: 490-494
        • Clark S.L.
        • Horenstein J.M.
        • Phelan J.P.
        • et al.
        Experience with the pulmonary artery catheter in obstetrics and gynecology.
        Am J Obstet Gynecol. 1985; 152: 374-378
        • Coevoet B.
        • Leuliet J.
        • Comoy E.
        • et al.
        Labetalol in the treatment of hypertension of pregnancy: Clinical effects and interactions with plasma renin and dopamine betahydroxylase activities, and with plasma concentrations of catecholamine.
        Kidney Int. 1980; 17: 701
        • Connell H.
        • Dalgleish J.G.
        • Downing J.W.
        General anaesthesia in mothers with severe pre-eclampsia/eclampsia.
        Br J Anaesth. 1987; 59: 1375-1380
        • Cotton D.B.
        • Benedetti T.J.
        Use of the Swan-Gwanz catheter in obstetrics and gynecology.
        Obstet Gynecol. 1980; 56: 641-645
        • Cotton D.B.
        • Gonik B.
        • Dorman K.F.
        Cardiovascular alterations in severe pregnancy-induced hypertension: Acute effects of intravenous magnesium sulfate.
        Am J Obstet Gynecol. 1984; 148: 162-165
        • Cotton D.B.
        • Gonik B.
        • Dorman K.
        • et al.
        Cardiovascular alterations in severe pregnancy-induced hypertension: Relationship of central venous pressure to pulmonary capillary wedge pressure.
        Am J Obstet Gynecol. 1985; 151: 762-764
        • Cotton D.B.
        • Jones M.M.
        • Longmire S.
        • et al.
        Role of intravenous nitroglycerin in the treatment of severe pregnancy-induced hypertension complicated by pulmonary edema.
        Am J Obstet Gynecol. 1986; 154: 91-93
        • Cotton D.B.
        • Lee W.
        • Huhta J.C.
        • et al.
        Hemodynamic profile of severe pregnancy-induced hypertension.
        Am J Obstet Gynecol. 1988; 158: 523-529
        • Cotton D.B.
        • Longmire S.
        • Jones M.M.
        • et al.
        Cardiovascular alterations in severe pregnancy-induced hypertension: Effects of intravenous nitroglycerin coupled with blood volume expansion.
        Am J Obstet Gynecol. 1986; 154: 1053-1059
        • Cunningham F.G.
        • Lowe T.
        • Guss S.
        • et al.
        Erythrocyte morphology in women with severe preeclampsia and eclampsia. Preliminary observations with scanning electron microscopy.
        Am J Obstet Gynecol. 1985; 153: 358-363
        • Dildy G.A.
        • Cotton D.B.
        Hemodynamic changes in pregnancy and pregnancy complicated by hypertension.
        Acute Care. 1991; 14-15 (1988-1989): 26-46
        • Donaldson J.O.
        Neurologic emergencies during pregnancy.
        in: Berkowitz R.L. Critical Care of the Obstetric Patient. Churchill Livingstone, New York1983: 367-383
        • Ducsay C.A.
        • Cook M.J.
        • Veille J.C.
        • et al.
        Cardiorespiratory effects of calcium channel-blocker tocolysis in pregnant rhesus monkeys.
        in: Jones C.T. Nathanielsz P.W. The physiological development of the fetus and newborn. Academic Press, London1985: 423-428
        • Duff P.
        Acute fatty liver of pregnancy.
        in: Clark S.L. Phelan J.P. Cotton C.B. Critical Care Obstetrics. Medical Economics Books, Oradell, NJ1987: 367
        • Dunn R.
        • Lee W.
        • Cotton D.B.
        Evaluation by computerized axial tomography of eclamptic women with seizures refractory to magnesium sulfate therapy.
        Am J Obstet Gynecol. 1986; 155: 267-268
        • Entman S.S.
        • Kambam J.R.
        • Bradley C.A.
        • et al.
        Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red cell turnover in preeclampsia.
        Am J Obstet Gynecol. 1987; 156: 1169-1173
        • Ferguson J.E.
        • Dyson D.C.
        • Schutz T.
        • et al.
        A comparison of tocolysis with nifedipine or ritodrine: Analysis of efficacy and maternal, fetal, and neonatal outcome.
        Am J Obstet Gynecol. 1990; 163: 105-111
        • Ferris T.F.
        • Weir E.K.
        Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit.
        J Clin Invest. 1983; 71: 809-815
        • Friedman S.A.
        Preeclampsia: A review of the role of prostaglandins.
        Obstet Gynecol. 1988; 71: 122-137
        • Gallery E.DM.
        • Hunyor S.N.
        • Gyory A.Z.
        Plasma volume contraction: A significant factor in both pregnancy-associated hypertension (preeclampsia) and chronic hypertension in pregnancy.
        Q J Med. 1979; 48: 593-602
        • Gibson B.
        • Hunter D.
        • Neame P.B.
        • et al.
        Thrombocytopenia in preeclampsia and eclampsia.
        Semin Thromb Hemost. 1982; 8: 234-247
        • Gonik B.
        • Cotton D.B.
        Peripartum colloid osmotic pressure changes: Influence of intravenous hydration.
        Am J Obstet Gynecol. 1984; 150: 99-100
        • Govan A.DT.
        The pathogenesis of eclamptic lesions.
        Pathol Microbiol (Basel. 1961; 24: 561-575
        • Graham C.
        • Goldstein A.
        Epidural analgesia and cardiac output in severe pre-eclamptics.
        Anaesthesia. 1980; 35: 709-712
        • Grunfeld J-P.
        • Pertuiset N.
        Acute renal failure in pregnancy: 1987.
        Am J Kidney Dis. 1987; 9: 359-362
        • Herbert W.NP.
        • Brenner W.E.
        Improving survival with liver rupture complicating pregnancy.
        Am J Obstet Gynecol. 1982; 142: 530-534
        • Herling I.M.
        Intravenous nitroglycerin: Clinical pharmacology and therapeutic considerations.
        Am Heart J. 1984; 108: 141-149
        • Hibbard B.M.
        • Rosen M.
        The management of severe preeclampsia and eclampsia.
        Br J Anaesth. 1977; 49: 3-9
        • Hibbard L.T.
        Maternal mortality due to acute toxemia.
        Obstet Gynecol. 1973; 42: 263-270
        • Hilmy M.I.
        • Somjen G.G.
        Distribution and tissue uptake of magnesium related to its pharmacological effects.
        Am J Physiol. 1968; 214: 406-413
        • Hodgkinson R.
        • Husain F.J.
        • Hayashi R.H.
        Systemic and pulmonary blood pressure during cesarean section in parturients with gestational hypertension.
        Can Anaesth Soc J. 1980; 27: 389-394
      51. Hughes H.C. Obstetric-Gynecologic Terminology. FA Davis, Philadelphia1972: 422-423
        • Hurault de Ligny B.
        • Ryckelynck J.P.
        • et al.
        Captopril therapy in preeclampsia.
        Nephron. 1987; 46: 329-330
        • Hurd W.W.
        • Miodovnik M.
        • Hertzberg V.
        • et al.
        Selective management of abruptio placentae: A prospective study.
        Obstet Gynecol. 1983; 61: 467-473
        • Jones M.M.
        • Longmire S.
        • Cotton D.B.
        • et al.
        Influence of crystalloid versus colloid infusion on peripartum colloid osmotic pressure changes.
        Obstet Gynecol. 1986; 68: 659-661
        • Jouppila P.
        • Jouppila R.
        • Hollmen A.
        • et al.
        Lumbar epidural analgesia to improve intervillous blood flow during labor in severe preeclampsia.
        Obstet Gynecol. 1982; 59: 158-161
        • Joyce T.H.
        • Debnath K.S.
        • Baker E.A.
        Preeclampsia—relationship of CVP and epidural analgesia.
        Anesthesiol. 1979; 51: S297
        • Kaunitz A.M.
        • Hughes J.M.
        • Grimes D.A.
        • et al.
        Causes of maternal mortality in the United States.
        Obstet Gynecol. 1985; 65: 605-612
        • Killam A.P.
        • Dillard S.H.
        • Patton R.C.
        • et al.
        Pregnancy-induced hypertension complicated by acute liver disease and disseminated intravascular coagulation.
        Am J Obstet Gynecol. 1975; 123: 823-828
        • Kirshon B.
        • Moise Jr., K.J.
        • Cotton D.B.
        • et al.
        Role of volume expansion in severe pre-eclampsia.
        Surg Gynecol Obstet. 1988; 167: 367-371
        • Kirshon B.
        • Lee W.
        • Mauer M.B.
        • et al.
        Effects of low-dose dopamine therapy in the oliguric patient with preeclampsia.
        Am J Obstet Gynecol. 1988; 159: 604-607
        • Koch-Weser J.
        Hydralazine.
        N Engl J Med. 1976; 295: 320-323
        • Krane N.K.
        Acute renal failure in pregnancy.
        Arch Intern Med. 1988; 148: 2347-2357
        • Kuwajima I.
        • Ueda K.
        • Kamata C.
        • et al.
        A study of the effects of nifedipine in hypertensive crises and severe hypertension.
        Jpn Heart J. 1978; 19: 455-467
        • Lamming G.D.
        • Symonds E.M.
        Use of labetalol and methyldopa in pregnancy-induced hypertension.
        Br J Clin Parmacol. 1979; 8: 217S-222S
        • Lindheimer M.D.
        • Katz A.I.
        Current concepts. Hypertension in pregnancy.
        N Engl J Med. 1985; 313: 675-680
        • Lubbe W.F.
        Hypertension in pregnancy: Whom and how to treat.
        Br J Clin Pharmacol. 1987; 24: 15S-20S
        • Lund-Johansen P.
        Short and long-term (6 year) hemodynamic effects of labetalol in essential hypertension.
        Am J Med. 1983; 75: 24-31
        • Lunell N.O.
        • Hjemdahl P.
        • Fredholm B.B.
        • et al.
        Circulatory and metabolic effects of a combined a and B-adrenoceptor blocker (Labetalol) in hypertension of pregnancy.
        Br J Clin Pharmacol. 1981; 12: 345-348
        • Lunell N.O.
        • Lewander R.
        • Mamoun I.
        • et al.
        Uteroplacental blood flow in pregnancy induced hypertension.
        Scand J Clin Lab Invest (Suppl. 1984; 169: 28-35
        • Mabie W.C.
        • Gonzalez A.R.
        • Sibai B.M.
        • et al.
        A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
        Obstet Gynecol. 1987; 70: 328-333
      71. Management of Preeclampsia, ACOG Technical Bulletin, No 91. The American College of Obstetricians and Gynecologists, Washington, DC1986: 1-5 (February)
        • Martin J.N.
        • Files J.C.
        • Blake P.G.
        • et al.
        Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome.
        Am J Obstet Gynecol. 1990; 162: 126-137
        • Martin J.N.
        • Files J.
        • Morrison J.C.
        Thrombotic thrombocytopenia purpura and hemolytic uremic syndrome in pregnancy.
        in: Clark S.L. Phelan J.P. Cotton D.B. Critical Care Obstetrics. Medical Economics Books, Oradell, NJ1987: 353
        • Massobrio M.
        • Benedetto C.
        • Bertini E.
        • et al.
        Immune complexes in preeclampsia and normal pregnancy.
        Am J Obstet Gynecol. 1985; 152: 578-583
        • Michael C.A.
        Use of labetalol in the treatment of severe hypertension during pregnancy.
        Br J Clin Pharmacol. 1979; 8: 211S-215S
        • Michael C.A.
        The evaluation of labetalol in the treatment of hypertension complicating pregnancy.
        Br J Clin Pharmacol. 1982; 13: 127S-131S
        • Miller J.D.
        The management of cerebral oedema.
        Br J Hosp Med. 1979; 21: 152-165
        • Mitchell S.E.
        • Clark R.A.
        Complications of central venous catheterization.
        AJR. 1979; 133: 467-476
        • Mroczek W.J.
        • Lee W.R.
        • Davidov M.E.
        Effect of magnesium sulfate on cardiovascular hemodynamics.
        Angiology. 1977; 28: 720-724
        • Naden R.P.
        • Redman C.WG.
        Antihypertensive drugs in pregnancy.
        Clin Perinatol. 1985; 12: 521-538
      81. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy.
        Am J Obstet Gynecol. 1990; 163: 1689-1712
        • Naulty J.
        • Cefalo R.C.
        • Lewis P.E.
        Fetal toxicity of nitroprusside in the pregnant ewe.
        Am J Obstet Gynecol. 1981; 139: 708-711
        • Newsome L.R.
        • Bramwell R.S.
        • Curling P.E.
        Severe preeclampsia: Hemodynamic effects of lumbar epidural anesthesia.
        Anesth Analg. 1986; 65: 31-36
        • Oates J.A.
        • Wood A.JJ.
        Converting-enzyme inhibitors in the treatment of hypertension.
        N Engl J Med. 1988; 319: 1517-1525
        • Parer J.T.
        • Livingston E.G.
        What is fetal distress?.
        Am J Obstet Gynecol. 1990; 162: 1421-1427
        • Pickles C.J.
        • Symonds E.M.
        • Pipkin F.B.
        The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension.
        Br J Obstet Gynecol. 1989; 96: 38-43
        • Pritchard J.A.
        The use of the magnesium ion in the management of eclamptogenic toxemias.
        Surg Gynecol Obstet. 1955; 100: 131-140
        • Pritchard J.A.
        The use of magnesium sulfate in preeclampsia-eclampsia.
        J Reprod Med. 1979; 23: 107-114
        • Pritchard J.A.
        • Brekken A.L.
        Clinical and laboratory studies on severe abruptio placentae.
        Am J Obstet Gynecol. 1967; 97: 681-695
        • Pritchard J.A.
        • Cunningham F.G.
        • Mason R.A.
        Coagualtion changes in eclampsia: Their frequency and pathogenesis.
        Am J Obstet Gynecol. 1976; 124: 855-864
        • Pritchard J.A.
        • Cunningham F.G.
        • Pritchard S.A.
        The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases.
        Am J Obstet Gynecol. 1984; 148: 951-963
      92. Hypertensive Disorders in Pregnancy.
        in: Pritchard J.A. MacDonald P.C. Gant N.F. Williams Obstetrics. ed. 17. Appleton-Century-Crofts, Norwalk, CT1985: 525
        • Pritchard J.A.
        • Pritchard S.A.
        Standardized treatment of 154 consecutive cases of eclampsia.
        Am J Obstet Gynecol. 1975; 123: 543-552
        • Pritchard J.A.
        • Weisman R.
        • Ratnoff O.D.
        • et al.
        Intravascular hemolysis, thrombocytopenia, and other hematologic abnormalities associated with severe toxemia of pregnancy.
        N Engl J Med. 1954; 250: 89-98
        • Rademaker L.
        Spontaneous rupture of liver complicating pregnancy.
        Ann Surg. 1943; 118: 396-401
        • Ram C.VS.
        • Kaplan N.M.
        Individual titration of diazoxide dosage in the treatment of severe hypertension.
        Am J Cardiol. 1979; 43: 627-630
        • Redman C.WG.
        Immunologic factors in the pathogenesis of preeclampsia.
        Contrib Nephrol. 1981; 25: 120
        • Redman C.WG.
        • Beilin L.J.
        • Bonnar J.
        • et al.
        Fetal outcome in trial of antihypertensive treatment in pregnancy.
        Lancet. 1976; 2: 753-756
        • Redman C.WG.
        • Beilin L.T.
        • Bonnar J.
        Renal function in pre-eclampsia.
        J Clin Pathol. 1976; 29: 91-94
        • Redman C.WG.
        • Beilin L.J.
        • Bonnar J.
        Treatment of hypertension in pregnancy with methyldopa. Blood pressure control and side effects.
        Br J Obstet Gynaecol. 1977; 84: 419-426
        • Riley A.J.
        Clinical pharmacology of labetalol in pregnancy.
        J Cardiovasc Pharmacol. 1981; 3: S53-S59
        • Romero R.
        • Lockwood C.
        • Oyarzun E.
        • et al.
        Toxemia: New concepts in an old disease.
        Semin Perinatol. 1988; 12: 302-323
        • Romero R.
        • Mazor M.
        • Lockwood C.J.
        • et al.
        Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension.
        Am J Perinatol. 1989; 6: 32-38
        • Romero R.
        • Vizoso J.
        • Emamian M.
        • et al.
        Clinical significance of liver dysfunction in pregnancy-induced hypertension.
        Am J Perinatol. 1988; 5: 146-151
        • Schubiger G.
        • Flury G.
        • Nussberger J.
        Enalapril for pregnancy-induced hypertension: Acute renal failure in a neonate.
        Ann Intern Med. 1988; 108: 215-216
        • Schwartz M.L.
        • Brenner W.
        Severe preeclampsia with persistent postpartum hemolysis and thrombocytopenia treated by plasmapheresis.
        Obstet Gynecol. 1985; 65: 53S-55S
        • Sheehan H.L.
        Pathological lesions in the hypertensive toxaemias of pregnancy.
        in: Hammond J. Browne F.J. Walstenholme G.EW. Toxaemias of pregnancy, human and veterinary. Blakiston, Philadelphia1950: 16-22
        • Shelley W.C.
        • Gutsche B.B.
        Magnesium and seizure control.
        Am J Obstet Gynecol. 1980; 136: 146-147
        • Shukla P.K.
        • Sharma D.
        • Mandal R.K.
        Serum lactate dehydrogenase in detecting liver damage associated with pre-eclampsia.
        Br J Obstet Gynaecol. 1978; 85: 40-42
        • Sibai B.M.
        Pitfalls in diagnosis and management of preeclampsia.
        Am J Obstet Gynecol. 1988; 159: 1-5
        • Sibai B.M.
        Magnesium sulfate is the ideal anticoagulant in preeclampsia-eclampsia.
        Am J Obstet Gynecol. 1990; 162: 1141-1145
        • Sibai B.M.
        • Graham J.M.
        • McCubbin J.H.
        A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia.
        Am J Obstet Gynecol. 1984; 150: 728-733
        • Sibai B.M.
        • Mabie B.C.
        • Harvey C.J.
        • et al.
        Pulmonary edema in severe preeclampsia-eclampsia: Analysis of 37 consecutive cases.
        Am J Obstet Gynecol. 1987; 156: 1174-1179
        • Sibai B.M.
        • Taslimi M.
        • Abdella T.N.
        • et al.
        Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester.
        Am J Obstet Gynecol. 1985; 152: 32-37
        • Sibai T.M.
        • Taslimi M.M.
        • El-Nazer A.
        • et al.
        Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe pre-eclampsia-eclampsia.
        Am J Obstet Gynecol. 1986; 155: 501-509
        • Sibai B.M.
        • Villar M.A.
        • Mabie B.C.
        Acute renal failure in hypertensive disorders of pregnancy. Pregnancy outcome and remote prognosis in 31 consecutive cases.
        Am J Obstet Gynecol. 1990; 162: 777-783
        • Smith L.G.
        • Moise K.J.
        • Dildy G.A.
        • et al.
        Spontaneous rupture of liver during pregnancy: Current therapy.
        Obstet Gynecol. 1991; 77: 171-175
        • Somjen G.
        • Hilmy M.
        • Stephen C.R.
        Failure to anesthetize human subject by intravenous administration of magnesium sulfate.
        J Pharmacol Exp Ther. 1966; 154: 652-659
        • Spargo B.
        • McCartney C.P.
        • Winemiller R.
        Glomerular capillary endotheliosis in toxemia of pregnancy.
        Arch Pathol. 1959; 68: 593-599
        • Spinnato J.A.
        • Sibai B.M.
        • Anderson G.D.
        Fetal distress after hydralazine therapy for severe pregnancy-induced hypertension.
        South Med J. 1986; 79: 559-562
        • Strauss R.G.
        • Keefer J.R.
        • Burke T.
        • et al.
        Hemodynamic monitoring of cardiogenic pulmonary edema complicating toxemia of pregnancy.
        Obstet Gynecol. 1980; 55: 170-174
        • Swan H.JC.
        • Ganz W.
        • Forrester J.
        • et al.
        Catheterization of the heart in man with the use of a flow-directed balloon-tipped catheter.
        N Engl J Med. 1970; 283: 447-451
        • Thien T.
        • Koene R.AP.
        • Schijf C.
        • et al.
        Infusion of diazoxide in severe hypertension during pregnancy.
        Eur J Obstet Gynecol Reprod Biol. 1980; 10: 367-374
        • Vardi J.
        • Fields G.A.
        Microangiopathic hemolytic anemia in severe preeclampsia.
        Am J Obstet Gynecol. 1974; 119: 617-622
        • Waisman G.D.
        • Mayorga L.M.
        • Camera M.I.
        • et al.
        Magnesium plus nifedipine: Potentiation of hypotensive effect in preeclampsia?.
        Am J Obstet Gynecol. 1988; 159: 308-309
        • Wasserstrum N.
        • Cotton D.B.
        Hemodynamic monitoring in severe pregnancy-induced hypertension.
        Clin Perinatol. 1986; 13: 781-799
        • Weil M.H.
        • Henning R.J.
        • Puri V.K.
        Colloid osmotic pressure: Clinical significance.
        Crit Care Med. 1979; 7: 113-116
        • Weinstein L.
        Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy.
        Am J Obstet Gynecol. 1982; 142: 159-167
        • Weinstein L.
        Preclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia.
        Obstet Gynecol. 1985; 66: 657-660
        • Weiss M.H.
        Cerebral edema.
        Acute Care. 1985; 11: 187-204
        • Worley R.J.
        Pathophysiology of pregnancy-induced hypertension.
        Clin Obstet Gynecol. 1984; 27: 821-835
        • Young B.K.
        • Weinstein H.M.
        Effects of magnesium sulfate on toxemic patients in labor.
        Obstet Gynecol. 1977; 49: 681-685

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0749-0704(18)30283-5

      Copyright

      © 1991 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX